In the context of the tumor microenvironment (TME), ligation of CD40 using agonist antibodies activates tumor associated macrophages (TAMs) to a pro-inflammatory, anti-tumorigenic phenotype that restricts tumor growth [3]. The gene discussed is CD40; the disease is neoplasm.